ESC 365 - Prognostic impact of spironolactone in patients with heart failure with preserved ejection fraction

HFA Premium Access

Prognostic impact of spironolactone in patients with heart failure with preserved ejection fraction

Session: Poster Session 1 - HFpEF - Heart failure with preserved ejection fraction

Topic: HFpEF - Heart failure with preserved ejection fraction

Speaker: Doctor M. Goncalves (Viseu, PT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Maria Luisa Goncalves

Hospital Sao Teotonio, Viseu (Portugal)

0 follower

14 more presentations in this session

Prevalence and correlates of left ventricular diastolic dysfunction in hypertensive community residents with preserved ejection fraction. Insights from survey-SEPHAR III

Speaker: Associate Professor A. Scafa Udriste (Bucharest, RO)

Hemodynamic correlates of right ventricular dilation in pulmonary hypertension due to HFpEF

Speaker: Doctor E. Berthelot (Le Kremlin-Bicetre, FR)

Left ventricular diastolic dysfunction and cardiovascular mortality in dialysis patients with preserved ejection fraction.

Speaker: Doctor J. Djamandi (Tirana, AL)

Left atrial volume index progresses significantly over time in diabetic and non-diabetic at risk populations

Speaker: Doctor G. O' Carroll (Tralee, IE)

Heart rate variability in heart failure patients with mid-range versus preserved ejection fraction and premature ventricular complexes

Speaker: Associate Professor G. Gheorghe (Bucharest, RO)

Access the full session

Poster Session 1 - HFpEF - Heart failure with preserved ejection fraction

Speakers: Doctor M. Goncalves, Associate Professor A. Scafa Udriste, Doctor E. Berthelot, Doctor J. Djamandi, Doctor G. O' Carroll...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources